Sign in / Join Now
ETFs & Funds
Current State Of Sangamo HIV Program (SGMO) $
Add a reply...
Latest StockTalks »
people get SGMO breaking news and analysis by email alert.
Get email alerts on SGMO »
Sangamo Therapeutics, Inc.
Get latest price
From other sites
Sangamo Therapeutics Receives Orphan Drug Designation From The FDA For SB-318 Genome Editing Treatment For MPS I
at TheStreet (Jan 11, 2017)
Sangamo Therapeutics Presents Latest Advances In Zinc Finger Nuclease Platform Technology At Keystone Symposium On Precision Genome Engineering
at TheStreet (Jan 10, 2017)
Sangamo BioSciences Changes Name To Sangamo Therapeutics, Underscoring Focus On Clinical Development Of Genomic Therapies
at TheStreet (Jan 6, 2017)
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-525 Gene Therapy Program For Hemophilia A
at TheStreet (Jan 5, 2017)
Sangamo BioSciences Announces Presentation At The 35th Annual J.P. Morgan Healthcare Conference
at TheStreet (Jan 4, 2017)